Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:3.1.1.34 (lipoprotein lipase)
7,025 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The lipoprotein lipase-catalyzed hydrolysis of triacylglycerol was determined in a lipid monolayer containing egg phosphatidylcholine and tri[14C]oleoylglycerol. In the presence of purified bovine milk lipoprotein lipase and fatty acid-free albumin, the rate of hydrolysis of tri[14C]oleoylglycerol, as determined by the decrease in surface activity, was dependent upon enzyme concentration and was enhanced by the addition of apolipoprotein C-II, the activator protein for the enzyme. Increasing the triacylglycerol content of the phospholipid monolayer from 1 to 6 mol% (relative to phospholipid) enhanced the rate of catalysis in the presence and absence of apolipoprotein C-II. However, at low substrate concentrations (less than 4 mol% tri[14C]oleoylglycerol), the activation factor for apolipoprotein C-II was greater than at high (4-6 mol%) triacylglycerol concentrations. The addition of sphingomyelin to the phosphatidylcholine monolayer decreased lipoprotein lipase activity. Based on these monolayer studies, we conclude that lipoprotein lipase catalyzes the hydrolysis of triacylglycerol at a phospholipid interface and that the rate of catalysis is dependent on the lipid composition of the monolayer.
...
PMID:Lipoprotein lipase-catalyzed hydrolysis of tri[14C]oleoylglycerol in a phospholipid interface. A monolayer study. 715 Jun 31

Apolipoprotein C-II, which activates lipoprotein lipase, was isolated from normal subjects and purified to homogeneity by reverse-phase high-pressure liquid chromatography (HPLC). The partially purified product from DEAE-cellulose chromatography was eluted from a Radial Pak C18 cartridge in a radial compression module using a linear gradient of 0.01 M ammonium bicarbonate and acetonitrile. The final product was homogeneous by polyacrylamide gel electrophoresis (pH 8.9), isoelectric focusing (pH 2.5-6.5), Ouchterlony double immunodiffusion, analytical HPLC and amino acid analysis. The purification of apolipoprotein C-II from normal subjects will permit the elucidation of its amino acid sequence and subsequent comparison with the known sequence of apolipoprotein C-II isolated from patients with hyperlipoproteinemia.
...
PMID:Purification and characterization of apolipoprotein C-II from human plasma by high-pressure liquid chromatography. 715 Jun 33

Bovine milk lipoprotein lipase (LpL) catalyzes the hydrolysis of the water-soluble esters p-nitrophenyl acetate (PNPA) and p-nitrophenyl butyrate (PNPB). The same protein and same active site are involved in hydrolysis of water-soluble p-nitrophenyl esters and emulsified trioleoylglycerol since (a) trioleoylglycerol hydrolysis and PNPB hydrolysis activities coelute from the heparin-Sepharose affinity column used to purify LpL and (b) LpL-catalyzed hydrolyses of trioleoylglycerol and PNPB are inhibited to equal extents by phenylmethanesulfonyl fluoride. The effect of apolipoprotein C-II (apoC-II) on the LpL-catalyzed hydrolysis of PNPA and PNPB has been determined. ApoC-II inhibits hydrolysis of both esters, with a maximum extent of inhibition of 70-90%. Inhibition of the LpL-catalyzed hydrolysis of PNPB is specific for apoC-II, since apolipoproteins A-I, C-I, and C-III-2 have little effect on this reaction, and is partial noncompetitive in form. KI values for apoC-II inhibition of the LpL-catalyzed hydrolysis of PNPA and PNPB are in the range 0.26-0.83 microM. The effect of apoC-II on the temperature dependences of LpL-catalyzed hydrolysis of both esters and on NaCl inhibition of LpL-catalyzed PNPB hydrolysis is consistent with a change in rate-determining step with LpL and apoC-II interact. These results indicate not only that there is an interaction between apoC-II and LpL in aqueous solution in the absence of a lipid interface but also that this interaction conformationally modulates the active site of the enzyme.
...
PMID:Lipoprotein lipase catalyzed hydrolysis of water-soluble p-nitrophenyl esters. Inhibition by apolipoprotein C-II. 715 70

The immunoreactivity of human plasma apolipoprotein C-II was investigated using a specific radioimmunoassay. In whole plasma, the mean value quantitated was 2.21 +/- 0.415 mg/dl, while in delipidated plasma, a mean value of 3.84 +/- 1.186 mg/dl was obtained, suggesting that the antigenic sites of the apolipoprotein were not fully detected in unmodified plasma by our antibody preparation. Two detergents, Tween-20 and Triton X-100, were studied to determine if they could enhance the immunoreactivity of apolipoprotein C-II in whole plasma. At concentrations of 0.012-0.06%, Tween-20 markedly increased the immunoreactivity of whole plasma, but not of delipidated plasma, indicating that antigenic sites of plasma apolipoprotein C-II has been exposed by Tween-20. In contrast, Triton X-100 had no effect on the immunoreactivity of whole plasma apolipoprotein C-II. A radioimmunoassay conducted in the presence of 0.06% Tween-20, resulted in a mean value in whole plasma (3.39 +/- 1.11 mg/dl) that was not significantly different from that obtained when the assay was done on delipidated samples. The immunoreactivity of VLDL apolipoprotein C-II was also drastically enhanced following lipolysis by bovine milk lipoprotein lipase, supporting the hypothesis that antigenic sites are masked by the lipids. Finally, the mechanism responsible for the effect of Tween-20 on apolipoprotein C-II immunoreactivity was investigated. The results obtained from circular dichroism and ultracentrifugation suggest that the detergent may dissociate the apolipoprotein from lipoprotein particles, thus fully exposing the antigenic sites for reaction with antibodies.
...
PMID:Immunochemistry of human plasma apolipoprotein C-II as studied by radioimmunoassay. 721 82

The rates of reaction of human lipoprotein lipase (EC 3.1.1.34) with triacylglycerol and partial acylglycerol substrates have been compared as a function of the concentration of lipase cofactor protein (apolipoprotein C-II). The data indicate that the dissociation constant for monoacylglycerol is approximately three orders of magnitude greater than for diacylglycerols, indicating that only when the concentrations of higher acylglycerols become vanishingly small will significant monoacylglycerol hydrolysis (from 1-monoacylglycerol generated by isomerization of the 2-substituted primary product) be mediated by the lipase. This is in spite of the fact that maximal reaction velocities with each of the potential substrates are similar. A 'lipolytic cycle' is proposed to explain binding and dissociation of substrates with cofactor-lipase complex during catabolism of triacylglycerols.
...
PMID:Characteristics of triacylglycerol and partial acylglycerol hydrolysis by human plasma lipoprotein lipase. 723 50

Cultured macrophages were shown to synthesize and constitutively secrete a triglyceride lipase identified as lipoprotein lipase on the basis of the following criteria: 1) it required apolipoprotein C-II for optimal activity; 2) it exhibited maximal activity at pH 8.2; 3) it was inhibited by 1 M NaCl; 4) it bound tightly to a heparin-Sepharose affinity gel and was eluted with buffer containing 1.5 M NaCl; and 5) the quantity of enzyme released from macrophages was enhanced by heparin. Cycloheximide treatment of macrophage cultures blocked the spontaneous secretion of lipoprotein lipase. Macrophage secretion of lipoprotein lipase may be relevant to the role of this cell in atherogenesis.
...
PMID:Secretion of lipoprotein lipase by macrophages in culture. 725 87

Very low density lipoproteins isolated from guinea pig liver perfusate (VLDLp) lack the equivalent of human apolipoprotein C-II (apoC-II), the activator of lipoprotein lipase (LpL). These lipoproteins are therefore ideal substrates with which to investigate the mechanism by which apoC-II activates the enzyme. VLDLp binds apoC-II, and apoC-II associated with VLDLp markedly increases the rate of lipoprotein lipase-catalyzed hydrolysis of VLDLp-triglycerides. The activator potency of apoC-II is independent of the method of enrichment of VLDLp with apoC-II: delipidated human apoC-II and apoC-II transferred from human high density lipoproteins activate lipoprotein lipase to equal extents. ApoC-II causes pH-dependent changes in both apparent Km and VmaX of LpL-catalyzed hydrolysis of VLDLp-triglycerides. At pH l7.4--7.5, the major effects of apoC-II is to decrease the apparent Km by 3.3--4.0 fold. The apparent Vmax is increased 1.3-fold. At pH 6.5 and 8.5, the decrease of apparent Km is less marked, 1.6-fold and 1.4-fold, respectively. At pH 6.5, apoC-II increases the apparent Vmax ty 1.3-fold, while at pH 8.5 the primary effect of apoC-II is a 1.6-fold increase of apparent Vmax. Based on a simple kinetic model, the data suggest that apoC-II favors direct interaction between enzyme and triglyceride within the lipoprotein particle, as well as subsequent catalytic turnover.
...
PMID:Hydrolysis of guinea pig nascent very low density lipoproteins catalyzed by lipoprotein lipase: activation by hjman apolipoprotein C-II. 727 52

Lipoprotein lipase of bovine aortic intima has been purified to homogeneity by affinity chromatography on heparin-Sepharose. As determine by polyacrylamide gel electrophoresis in sodium dodecyl sulfate, the purified enzyme had a molecular weight of approximately 60,000, required apolipoprotein C-II for activity and was inhibited by 1.0 M NaCl. Optimum lipolytic activity was in the pH range of 8.0-8.5. Bovine skimmed milk lipoprotein lipase was also purified and its properties compared to those of the aortic enzyme. Based on these comparative studies, we conclude that bovine aortic and milk lipoprotein lipase have similar properties.
...
PMID:Purification and properties of bovine aortic lipoprotein lipase. 743 42

Purified bovine milk lipoprotein lipase has been covalently attached to CH-Sepharose with water-soluble carbodiimide. The immobilized enzyme retained enzymic activity and was stimulated 7-fold by the addition of human apolipoprotein C-II. Both [3H]heparin and 125I-labeled apolipoprotein C-II bound to the immobilized enzyme; unlabeled heparin and apolipoprotein C-II competed for binding of their respective labeled compounds. Apolipoprotein C-II did not compete for binding of [3H]heparin and vice versa. Human apolipoprotein C-III did not bind to the immobilized enzyme nor did it compete for apolipoprotein C-II binding. We conclude from these studies that both apolipoprotein C-II and heparin interact with immobilized lipoprotein lipase and that they have different binding sites.
...
PMID:Preparation and properties of immobilized lipoprotein lipase. 743 56

The polypeptide composition of a variant lipoprotein (d less than 1.006) carrying a relative excess of apolipoprotein C-II has been characterised by polyacrylamide gel electrophoresis and isoelectric focussing. The apo-C peptides of the variant lipoprotein contained 45.2 +/- 1.3 (n = 9) % of apo C-II compared with 21.5 +/- 5.4 (n = 30) % for hypertriglyceridaemic controls. The variant lipoprotein activated purified bovine milk lipoprotein lipase normally, but was an inefficient substrate for this enzyme as assessed by direct release of fatty acids from the lipoprotein or by a substrate competition assay. Electron microscopy revealed the variant lipoprotein as non-spherical flattened particles compared with the more spherical appearance of control triglyceride-rich lipoproteins. We suggest that the relative proportion of apo C peptides associated with the lipoprotein particle may be critical for optimal enzyme-substrate interaction.
...
PMID:An abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-II. 747 Jan 92


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>

---